122 related articles for article (PubMed ID: 36327945)
1. Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
Okumura T; Noguchi T; Sekiguchi N; Kobayashi T; Kanda S; Ida K; Minagawa T; Tokumaru S; Umemura T; Koizumi T
Chemotherapy; 2023; 68(2):87-94. PubMed ID: 36327945
[TBL] [Abstract][Full Text] [Related]
2. Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.
Nio K; Arita S; Isobe T; Kusaba H; Kohashi K; Kajitani T; Tamura S; Hirano G; Mitsugi K; Makiyama A; Esaki T; Ariyama H; Oda Y; Akashi K; Baba E
Cancer Chemother Pharmacol; 2015 Apr; 75(4):829-35. PubMed ID: 25702050
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma.
Kobayashi N; Takeda Y; Okubo N; Suzuki A; Tokuhisa M; Hiroshima Y; Ichikawa Y
Cancer Sci; 2021 May; 112(5):1936-1942. PubMed ID: 33453146
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy].
Funasaka C; Kanemasa Y; Kageyama A; Shimoyama T; Omuro Y
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1205-1208. PubMed ID: 32829355
[TBL] [Abstract][Full Text] [Related]
5. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer.
de M Rêgo JF; de Medeiros RSS; Braghiroli MI; Galvão B; Neto JEB; Munhoz RR; Guerra J; Nonogaki S; Kimura L; Pfiffer TE; de Castro G; Hoff PM; Filho DR; Costa FP; Riechelmann RP
Ecancermedicalscience; 2017; 11():767. PubMed ID: 28955403
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary small-cell carcinoma: a single-institution experience.
Kim JH; Lee SH; Park J; Kim HY; Lee SI; Nam EM; Park JO; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K
Jpn J Clin Oncol; 2004 May; 34(5):250-4. PubMed ID: 15231859
[TBL] [Abstract][Full Text] [Related]
7. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.
Aytac E; Ozdemir Y; Ozuner G
J Visc Surg; 2014 Feb; 151(1):3-7. PubMed ID: 24412088
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
9. Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues.
Volante M; Birocco N; Gatti G; Duregon E; Lorizzo K; Fazio N; Scagliotti GV; Papotti M
Hum Pathol; 2014 Apr; 45(4):665-73. PubMed ID: 23806528
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
Wee CE; Costello BA; Orme JJ; Quevedo JF; Pagliaro LC
Prostate; 2021 Sep; 81(13):938-943. PubMed ID: 34254332
[TBL] [Abstract][Full Text] [Related]
13. [Extrapulmonary small cell carcinoma in 52 patients].
Yuan ZY; Guan ZZ; Zhou ZM; Xia Y; Huang WZ; Yang XL
Ai Zheng; 2006 Sep; 25(9):1131-3. PubMed ID: 16965656
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.
Sağnıç S; Birge Ö; Bakır MS; Karadag C; Şimşek T
Int J Surg Oncol; 2021; 2021():8290659. PubMed ID: 34567803
[TBL] [Abstract][Full Text] [Related]
16. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
17. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
19. Extrapulmonary small cell carcinoma: single center experience with 61 patients.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kim WK; Lee JS; Jang SJ; Khang SK; Kang YK
Acta Oncol; 2007; 46(6):846-51. PubMed ID: 17653910
[TBL] [Abstract][Full Text] [Related]
20. Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Vrontis K; Economidou SC; Fotopoulos G
Cancer Invest; 2022 Feb; 40(2):124-131. PubMed ID: 34601985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
